Sonoma Pharmaceuticals's total assets for Q4 2025 were $13.69M, an increase of 0.18% from the previous quarter. SNOA total liabilities were $9.28M for the fiscal quarter, a 5.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.